• Issue

    Clinical Genetics: Volume 99, Issue 1

    1-214
    January 2021

ISSUE INFORMATION

Free Access

Issue Information

  • Page: 1
  • First Published: 27 December 2020

REVIEWS

Full Access

The role of long non-coding RNAs in drug resistance of cancer

  • Pages: 84-92
  • First Published: 25 June 2020
The role of long non-coding RNAs in drug resistance of cancer

LncRNAs regulate cell drug resistance through competing with miRNAs or targeting genes, or mediating related signal pathways.

Full Access

Autosomal dominant neuronal ceroid lipofuscinosis: Clinical features and molecular basis

  • Pages: 111-118
  • First Published: 12 August 2020
Autosomal dominant neuronal ceroid lipofuscinosis: Clinical features and molecular basis

EM study of peripheral lymphocytes of autosomal dominant neuronal ceroid lipofuscinosis (ADNCL) patient's storage inclusions granular osmophilic deposits (GROD) on the left, and GROD and rectilinear body (RB) mixed type on the right. CSPα−/− primary mouse cortical neurons were lentivirally infected with myc-tagged CSPαWT, CSPαL115R, CSPαL116Δ, or empty lentivirus (control) on 7 days in vitro (DIV) and examined on 17 DIV. CSPα variants were visualized by immunofluorescence against myc (green); somatodendrites were visualized by anti-MAP2 (red); nuclei were stained by DAPI (blue). CSPαWT formed distinct puncta, indicating presynapses, along dendrites, while mutant CSPα aggregates showed largely diffuse staining in the soma away from presynapses.

ORIGINAL ARTICLES

Full Access

Age of onset and behavioral manifestations in Huntington's disease: An Enroll-HD cohort analysis

  • Pages: 133-142
  • First Published: 05 October 2020
Age of onset and behavioral manifestations in Huntington's disease: An Enroll-HD cohort analysis

Huntington's disease is a autosomal dominant trinucleotide repeat disorder that results in motor, behavioral and cognitive dysfunction. Onset is usually in midlife but symptoms may start in childhood or late in life. Age of onset in relation to behavioral presentations were explored using a large manifest cohort. An inverse relationship was noted between age of onset and behavioral symptom presentations, highlighting an age associated difference in phenotypic presentations of Huntington's disease.

Full Access

Exploring genotype-phenotype relationships in the CDKL5 deficiency disorder using an international dataset

  • Pages: 157-165
  • First Published: 12 October 2020
Exploring genotype-phenotype relationships in the CDKL5 deficiency disorder using an international dataset

This study is the first exploration of genotype-phenotype relationships for 13 recurrent variants in CDKL5. We also re-examined the historic variant groupings previously used to investigate variants for the CDKL5 deficiency disorder. By applying two recently developed measures, we demonstrated that p.Arg178Trp, p.Arg559* and p.Arg178Gln variants produce severe phenotypes while variants producing milder phenotypes included p.Arg134*, p.Arg550* and p.Glu55Argfs*20. Our novel findings highlight the need for continued international collaboration between research groups to facilitate large study sizes and meaningful results for rare genetic conditions like the CDKL5 deficiency disorder.

SHORT REPORTS

Open Access

QRICH1 variants in Ververi-Brady syndrome—delineation of the genotypic and phenotypic spectrum

  • Pages: 199-207
  • First Published: 03 October 2020
QRICH1 variants in Ververi-Brady syndrome—delineation of the genotypic and phenotypic spectrum

The Ververi-Brady syndrome is a rare developmental disorder with a lot of hallmarks that are rather unspecific. We tried to further delineate the symptoms in this this study. Speech delay and notable social behaviour deficits seem to be the key symptoms. Our patients, as well as those described in the literature, all show mutations in the QRICH1 gene. We found three new variants that have not yet been described as well as one that has already been identified.